Veru (VERU) Earnings Date & Reports

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS)... Show more

Industry: #Household Or Personal Care

Get AI intraday signals

A.I. Advisor

published Earnings

VERU is expected to report earnings to rise 1.50% to -6 cents per share on May 07

Q1'25

Est.

$-0.06

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.01

Q1'24

Missed

by $0.01

The last earnings report on February 13 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 911.42K shares outstanding, the current market capitalization sits at 75.14M.

View a ticker or compare two or three

Compare

VERU